|
THE FIFTH ANNUAL ELIZABETH
TAYLOR BALL TO END AIDS
TO HONOR RICHARD DICKSON, CEO OF GAP INC.,
ON SEPTEMBER 26, 2024
LOS ANGELES -
The Elizabeth Taylor AIDS Foundation (ETAF) today
announced Richard Dickson, President and CEO of Gap
Inc., will be honored with The Elizabeth Taylor
Commitment to End AIDS Award at the fifth annual Elizabeth
Taylor Ball to End AIDS on September 26, 2024 at The
Beverly Hills Hotel. The evening will be generously
supported by Presenting Sponsor Gilead Sciences.
Model, actress, and author Dominique
Jackson will serve as MC. The Elizabeth Taylor Ball
to End AIDS will include a seated dinner, an exciting
live auction in partnership with Christie’s featuring unique
experiences, a live performance, and an exclusive look at
items from The Elizabeth Taylor Archive including highlights
from Elizabeth Taylor’s personal life, film career, and
philanthropy.
Dickson has long supported people affected by
HIV and AIDS, especially through his support of the Children
Affected by AIDS Foundation. He formerly served on the Board
of Directors for the UCLA Mattel Children’s Hospital, and
currently serves on the Board of Advisors for The Robert H.
Smith School of Business at The University of Maryland. And
as Gap Inc. CEO since August 2023, Dickson leads a $15
billion house of iconic American brands, including Old Navy,
Gap, Banana Republic and Athleta, which are renowned for
doing more than selling clothes. They are purpose-led brands
that shape culture and bridge critical gaps in society –
from equity and opportunity, to inclusion and
sustainability.
“The Elizabeth Taylor AIDS Foundation is
thrilled to honor Richard Dickson with The Elizabeth
Taylor Commitment to End AIDS Award at this year’s gala
for his unwavering and admirable dedication over the years
to helping people affected by HIV and AIDS. It’s his
purpose-driven leadership across business, brands and
philanthropy that makes all the difference,” said Catherine
Brown, Executive Director, The Elizabeth Taylor AIDS
Foundation.
# # #
ABOUT ETAF
Working tirelessly on the AIDS crisis
throughout the 1980s, Elizabeth Taylor established The
Elizabeth Taylor AIDS Foundation (ETAF) in 1991 to carry out
her vision for an AIDS-free world. ETAF works to provide the
direct care needed for people living with and affected by
HIV and AIDS. Emphasizing Elizabeth's voice, commitment, and
concentration on hard-to-reach communities, ETAF's domestic
advocacy initiatives remain a priority. ETAF's programs have
also expanded to ensure that HIV prevention education and
access to treatment are available through domestic and
international initiatives.
For more information, visit ETAF.org or
contact Cathy Brown, ETAF, at cbrown@etaf.org.
ABOUT GILEAD SCIENCES
Gilead Sciences, Inc. is a biopharmaceutical
company that has pursued and achieved breakthroughs in
medicine for more than three decades, with the goal of
creating a healthier world for all people. The company is
committed to advancing innovative medicines to prevent and
treat life-threatening diseases, including HIV, viral
hepatitis, COVID-19, and cancer. Gilead operates in more
than 35 countries worldwide, with headquarters in Foster
City, Calif.
|